Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience

類似資料

• Vitamin D and urological cancers
  著者:: Krajewski, Wojciech, 等
  出版事項: (2016)
• Evaluation and physiopathology of minor transient shock wave lithotripsy – induced renal injury based on urinary biomarkers levels
  著者:: Dzięgała, Mateusz, 等
  出版事項: (2018)
• Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy
  著者:: Piszczek, Radosław, 等
  出版事項: (2020)
• Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
  著者:: Wojciech Krajewski, 等
  出版事項: (2020-10-01)
• Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
  著者:: Krajewski, Wojciech, 等
  出版事項: (2020)